PPD, Inc. has expanded its clinical microbiology laboratory at its global central laboratories worldwide, strengthening its laboratory testing services in infectious diseases.

According to a company statement, PPD can now offer clients a full range of microbiology testing services, such as bacteriology, mycobacteriology and testing of microbioterrorism pathogens. The laboratory also provides extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and single nucleotide polymorphism analysis. The laboratory has the capability to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms. PPD is currently running studies for staphylococcal and yeast infections and for the presumptive identification and quantification of microbiota.

“Microbiology is an important component of laboratory testing for infectious diseases,” said Elena Logan, senior vice president of global central labs for PPD. “Strengthening our microbiology capabilities demonstrates PPD’s commitment to deliver a full range of high quality global central laboratory services and builds on our fully integrated clinical research and development expertise across all areas of infectious diseases.”